Gail Jones, MD
Urology · Little Rock, ARNPI 1467427146
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $111,000 of the $127,576 with a category attached, or 87.0%. Cryo Specialty Medical, LLC accounts for 94.5% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $38,960 and has fallen 98.4% since, to $639 in 2025. Among urology clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 270 payments — averaging $472.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cryo Specialty Medical, LLC$121K
- Teleflex LLC$1K
- Astellas Pharma US Inc$587
- Johnson & Johnson$526
- AbbVie$518
- Dendreon Pharmaceuticals LLC$466
- plus $4K from 25 others
What the payments were for
- Speaking & faculty fees$9,5007%
- Travel & lodging$1,1931%
- Food & beverage$5,7935%
- Education$900%
- Ownership interest$111,00087%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cryo Specialty Medical, LLC | 5 | $120,500 |
| Teleflex LLC | 5 | $1,202 |
| Astellas Pharma US Inc | 26 | $587 |
| Johnson & Johnson | 33 | $526 |
| AbbVie(2 entities) | 34 | $518 |
| Dendreon Pharmaceuticals LLC | 11 | $466 |
| Myriad Genetic Laboratories, Inc. | 8 | $443 |
| Myovant Sciences Inc. | 21 | $437 |
| Endo Pharmaceuticals Inc. | 10 | $409 |
| Antares Pharma, Inc. | 22 | $392 |
| Axonics, Inc. | 5 | $327 |
| Tolmar, Inc. | 19 | $252 |
| Sumitomo Pharma America, Inc. | 11 | $227 |
| Amgen | 6 | $177 |
| Boston Scientific | 8 | $148 |
| Endo USA, Inc. | 5 | $121 |
| Blue Earth Diagnostics | 5 | $114 |
| Pfizer | 7 | $95 |
| Urovant Sciences Inc | 5 | $81 |
| Neotract Inc. | 1 | $80 |
| Urogen Pharma, Inc. | 2 | $66 |
| Coloplast | 4 | $64 |
| Bayer | 4 | $64 |
| Merck | 3 | $59 |
| Verity Pharmaceuticals Inc. | 2 | $50 |
| Ferring Pharmaceuticals Inc. | 2 | $50 |
| Halozyme Inc | 2 | $37 |
| Baudax Bio Inc. | 1 | $23 |
| AstraZeneca | 1 | $22 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Clovis Oncology, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$127,576 in reported general payments places this provider in the 90th percentile of 88 urology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Testosterone Cypionate | 228 | $9,700 |
| Testosterone | 29 | $7,735 |
| Tamsulosin Hcl | 203 | $3,229 |
| ValacyclovirValacyclovir Hcl | 14 | $1,752 |
| Finasteride | 85 | $1,212 |
| Oxybutynin Chloride ErOxybutynin Chloride | 41 | $995 |
| Dutasteride | 13 | $229 |
| Anastrozole | 79 | $205 |
Paid to pharmacies, not to this prescriber.
Other urology in Little Rock
- Donald MooneyLittle Rock$148K
- Timothy GoodsonLittle Rock$147K
- Caleb BozemanLittle Rock$136K
- David CoussensLittle Rock$134K
- Timothy LangfordLittle Rock$133K
- Kevin ClaybrookLittle Rock$132K
- John MooreLittle Rock$19K
- Michael ChildsLittle Rock$8K
- Bruno Lopes Cancado MachadoLittle Rock$7K
- Marcelo BigarellaLittle Rock$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.